Zusammenfassung
Seit vielen Jahren sucht man nach adäquaten, praxisrelevanten Konzepten, um einerseits präventiv den Problemen des Alkoholentzugssyndroms begegnen zu können, andererseits alkoholkranken Patienten eine medikamentöse und psychotherapeutische Hilfe zu bieten mit dem Ziel, die Sucht zu überwinden. Aus medikamentöser Sicht werden hierzu weltweit ca. 150 Substanzen mit unterschiedlichen pharmakologischen Angriffspunkten und unterschiedlichen Erfolgen eingesetzt. Wünschenswert wäre es, zur Prävention bzw. zur Behandlung des Alkoholentzugssyndroms ein kausal anwendbares Therapieschema zu finden. Dies ist bis heute noch nicht gelungen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Athen D, Beckmann H, Ackenheil M, Markianos M (1977) Biochemical investiga-tions into the alcoholic delirium. Alterations of biogenic amines. Arch Psychiatr Nervenkr 224:129–140
Björkqvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiatr Scand 52:256–263
Borg S, Kvande H, Sedvall G (1981) Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 213:1135–1137
Borg S, Czarnecka A, Kvande H, Mossberg D, Sedvall G (1983) Clinical conditions and concentrations of MOPEG in the cerebrospinal cluid and urine of male alcoholic patients during withdrawal. Alcoholism 7:411–415
Brämswig H, Schuster H-P, Bodmann KF (1992) Das Alkoholdelir in der internen Intensivmedizin. Intensivmedizin 29:329–333
Charney DS, Heninger GR, Kleber HD (1986) The combined use of Clonidine and Naltrexone as a rapid save, and effective treatment of the abrupt withdrawal from Methadone. Am J Psychiatry 143:831–837
Cedarbaum JM, Aghajanian CK (1976) Noradrenergic neurons of the locus coeruleus:Inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Br Res 112:413–419
Cushman P, Sowers JR (1989) Alcohol withdrawal syndrom:Clinical and hormonal responses to alpha-2-adrenergic agonist treatment. Alcohol Clin Exp Res 13:361–364
Fujimoto A, Nagao T, Ebara T, Sato M, Otuski S (1983) Cerebrospinal fluid mono-amine metabolites during alcohol withdrawal syndrom and recovered state. Biol Psychiatry 18:1141–1152
Glue P, Nutt D (1987) Clonidine in alcohol withdrawal:A pilot study of differential symptoms responses following i.v. Clonidine. Alcohol & Alcoholism 22:161–166
Gold MS, Redmond DE, Kleber HD (1978) Clonidine blocks acute opiate withdrawal symptomes. Lancet 11:929–930
Gold MS, Pottash AC, Sweeney DR, Kleber HD (1980) Opiate withdrawal using Clonidine. JAMA 243:343–346
Gold MS, Roehrich H (1987) Treatment of opiate withdrawal with Clonidine. ISI Atlas of Science, pp 29–32
Griffiths PJ, Littleton JM, Ortiz A (1974) Changes in monoamine concentration in mouse brain associated with ethanol dependance and withdrawal. Br J Pharmakol 50:589–598
Hausen M, Vogel A (1984) Hochdosierte Clonidintherapie. Ein neuer Weg zur Beherrschung des Alkoholentzugsdelirs? Verh Dtsch Ges Inn Med 90:934–937
Hawley RJ, Major LF, Schulman EA, Lake CR (1981) CDF levels of norepinephrine during alcohol withdrawal. Arch Neurol 38:289–292
Hawley RJ, Major LF, Schulman EA, Linnoila M (1985) Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Arch Gen Psychiatry 42:1056–1062
Heuzeroth L, Grüneklee D (1988) Clonidin — eine Alternative in der Behandlung des Delirium tremens. Med Klin 83:783–789
Kleber HD, Riordan CE, Rounsaville B, Kosten T, Charney D, Gaspari J, Hogan I, O’Connor C (1985) Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry 42:391–394
Kobayashi RM, Palkovics M, Jacobowitz M, Kopin IJ (1975) Biochemical mapping of the noradrenergic projection from the locus coeruleus. Neurology 25:223–233
Kostowski W, Trzaskowska E (1980) Effects of the locus coeruleus and Clonidine treatment on ethanol withdrawal syndrom in rats. J Pharmacol Pharm 32:617
Lynch M, Littleton J, McKernan RM, Durcan MJ, McMillan T, Campbell IC (1983) Alpha-adrenoceptor number and function in rat cortex after ethanol and immobilisation stress. Br Res 288:145–149
Manham P, Nilsson LH, Moberg AL, Wadstein J, Hökfelt B (1985) Alcohol withdrawal:Effects of Clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcohol & Alcoholism 22:161–166
Metz G, Nebel B (1983) Clonidin beim schweren Alkoholentzugsdelir. Fortschr Med 101:1260–1264
Mühlbauer S (Hrsg) (1991) Die Delirbehandlung mit Clonidin. Fortschr Med 109, Monographie 33
Nutt DJ, Glue P (1986) Monoamines and alcohol. Br J Addict 81:327–338
Nutt D, Glue P, Molyneux S, Clark E (1988) Alpha-2-adrenoceptor function in alcohol withdrawal:A pilot study of the effects of i.v. Clonidine in alcoholics and normal. Alcohol Clin Exp Res 12:14–18
Rosenfeld B (1984) Cigarette craving, smoking, withdrawal, and Clonidine. Science 226:864–866
Schinzel H, Weilemann LS, Swars H, Kelbel C, Meyer J (1993) Erfahrungen bei der Behandlung schwerer Alkoholentzugssyndrome auf einer internistischen Intensiv-station mittels Clonidin. Intensivmedizin 30:79–83
Schuchardt V, Schwarzer W (1991) Therapie des schweren Alkoholdelirs. Intensivmedizin 28:231–237
Sjöquist B, Borg S, Kvande H (1981) Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Sub Alcohol Actions/Misuse 2:63–72
Täschner K-L (1985) Zur Wirkung von Clonidin bei der Behandlung des Entzugssyndroms Opiatsüchtiger. Med Klin 80:664–667
Wrobel N, Thalhofer S, Köppel C (1991) Clonidintherapie beim Alkoholentzugssyndrom bei Intensivpatienten. Intensiv- und Notfallbehandlung 16:113–116
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schinzel, H. (1994). Clonidin. In: Tretter, F., Bussello-Spieth, S., Bender, W. (eds) Therapie von Entzugssyndromen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78778-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-78778-2_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57638-9
Online ISBN: 978-3-642-78778-2
eBook Packages: Springer Book Archive